Alcoholism, also known as alcohol use disorder (AUD), is a chronic and debilitating condition characterized by an inability to control or limit alcohol consumption despite its negative consequences on physical health, mental well-being, relationships, and overall life satisfaction. Individuals with alcoholism often experience an intense craving for alcohol and may prioritize its consumption over other responsibilities and obligations. The causes of alcoholism are multifaceted and can include genetic predispositions, environmental factors, psychological influences, and social pressures. Genetic factors play a significant role, with studies suggesting that certain genetic variations may increase the risk of developing AUD. Environmental influences such as stress, trauma, peer pressure, and exposure to heavy drinking can also contribute to the development of alcoholism. Alcoholism can lead to a wide range of health problems, including liver disease, cardiovascular issues, neurological impairments, gastrointestinal disorders, and an increased risk of certain cancers. Additionally, individuals with alcoholism are at a higher risk of experiencing mental health disorders such as depression, anxiety, and psychosis. Treatment for alcoholism often involves a combination of medical intervention, therapy, support groups, and lifestyle changes. Detoxification may be necessary to manage withdrawal symptoms, followed by ongoing therapy and support to address the underlying issues contributing to alcohol abuse. Support from friends, family, and healthcare professionals is crucial in the recovery process, as alcoholism can be challenging to overcome alone. Early intervention and comprehensive treatment strategies are essential for improving outcomes and reducing the devastating impact of alcoholism on individuals and society.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom